Rezultati - Germing, Ulrich

Refine Results
  1. 1
    Correspondence (reply): In Reply

    Correspondence (reply): In Reply od Germing, Ulrich

    Izdano 2014
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Reply to “Acute leukemia arising after radioiodine treatment for thyroid cancer” Haematologica 2012;97(8):e28–29

    Reply to “Acute leukemia arising after radioiodine treatment for thyroid cancer” Haematologica 2012;97(8):e28–29 od Schroeder, Thomas, Germing, Ulrich

    Izdano 2012
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Mastering the multitude of monocytoses

    Mastering the multitude of monocytoses od Germing, Ulrich, Gattermann, Norbert

    Izdano 2019
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview

    Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview od Kuendgen, Andrea, Kasprzak, Annika, Germing, Ulrich

    Izdano 2021
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment

    Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment od Germing, Ulrich, Kobbe, Guido, Haas, Rainer, Gattermann, Norbert

    Izdano 2013
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Mesenchymal stromal cells in myeloid malignancies

    Mesenchymal stromal cells in myeloid malignancies od Schroeder, Thomas, Geyh, Stefanie, Germing, Ulrich, Haas, Rainer

    Izdano 2016
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)

    Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS) od Kasprzak, Annika, Nachtkamp, Kathrin, Gattermann, Norbert, Germing, Ulrich

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies

    Treatment of Anemia in Transfusion-Dependent and Non-Transfusion-Dependent Lower-Risk MDS: Current and Emerging Strategies od Germing, Ulrich, Oliva, Ester N., Hiwase, Devendra, Almeida, Antonio

    Izdano 2019
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes

    Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes od Giagounidis, Aristoteles A N, Germing, Ulrich, Haase, Sabine, Aul, Carlo

    Izdano 2007
    Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with granulocyte colony-stimulating factor (G-CSF): A case report

    A patient with glycogen storage disease type Ib presenting with acute myeloid leukemia (AML) bearing monosomy 7 and translocation t(3;8)(q26;q24) after 14 years of treatment with g... od Schroeder, Thomas, Hildebrandt, Barbara, Mayatepek, Ertan, Germing, Ulrich, Haas, Rainer

    Izdano 2008
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment

    Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and Treatment od Rautenberg, Christina, Germing, Ulrich, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas

    Izdano 2019
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Impaired formation of neutrophil extracellular traps in patients with MDS

    Impaired formation of neutrophil extracellular traps in patients with MDS od Brings, Carolin, Fröbel, Julia, Cadeddu, Patrick, Germing, Ulrich, Haas, Rainer, Gattermann, Norbert

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival

    Low RPS14 expression is common in myelodysplastic syndromes without 5q- aberration and defines a subgroup of patients with prolonged survival od Czibere, Akos, Bruns, Ingmar, Junge, Bärbel, Singh, Raminder, Kobbe, Guido, Haas, Rainer, Germing, Ulrich

    Izdano 2009
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action?

    Guidelines for Myelodysplastic Syndromes: Converting Evidence into Action? od Kasprzak, Annika, Kaivers, Jennifer, Nachtkamp, Kathrin, Haas, Rainer, Kobbe, Guido, Gattermann, Norbert, Germing, Ulrich

    Izdano 2021
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes

    Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes od Giagounidis, Aristoteles, Mufti, Ghulam J., Fenaux, Pierre, Germing, Ulrich, List, Alan, MacBeth, Kyle J.

    Izdano 2013
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome

    The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome od Zipperer, Esther, Pelz, Daniela, Nachtkamp, Kathrin, Kuendgen, Andrea, Strupp, Corinna, Gattermann, Norbert, Haas, Rainer, Germing, Ulrich

    Izdano 2009
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients

    Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients od Silzle, Tobias, Blum, Sabine, Schuler, Esther, Kaivers, Jennifer, Rudelius, Martina, Hildebrandt, Barbara, Gattermann, Norbert, Haas, Rainer, Germing, Ulrich

    Izdano 2019
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system

    The myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system od Zipperer, Esther, Tanha, Nina, Strupp, Corinna, Kündgen, Andrea, Nachtkamp, Kathrin, Neukirchen, Judith, Hildebrandt, Barbara, Haas, Rainer, Gattermann, Norbert, Germing, Ulrich

    Izdano 2014
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS

    Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS od Rautenberg, Christina, Germing, Ulrich, Pechtel, Sabrina, Lamers, Marius, Fischermanns, Carolin, Jäger, Paul, Geyh, Stefanie, Haas, Rainer, Kobbe, Guido, Schroeder, Thomas

    Izdano 2019
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations

    Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectation... od Boquoi, Amelie, Rings, Veronika, Mohring, Annemarie, Savickaite, Ingrida, Zukovs, Romans, Strapatsas, Judith, Nachtkamp, Kathrin, Kobbe, Guido, Germing, Ulrich, Fenk, Roland

    Izdano 2022
    Polni tekst Polni tekst Polni tekst
    Text
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: